Supplementary Figure 4 from AZD2014, an Inhibitor of Mtorc1 and Mtorc2, is Highly Effective in ER+ Breast Cancer when Administered Using Intermittent or Continuous Schedules | AMiner
Supplementary Figure 4 from AZD2014, an Inhibitor of Mtorc1 and Mtorc2, is Highly Effective in ER+ Breast Cancer when Administered Using Intermittent or Continuous Schedules
原文链接
分享
引用
